Anavex Life Sciences Corp. (AVXL)
1.15
+0.04
(+3.60%)
USD |
NASDAQ |
Nov 06, 16:00
1.145
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Price to Book Value : 0.948 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 0.948 |
| November 05, 2026 | 0.915 |
| November 04, 2026 | 1.039 |
| November 03, 2026 | 0.9892 |
| November 02, 2026 | 0.9398 |
| October 30, 2026 | 0.981 |
| October 29, 2026 | 1.072 |
| October 28, 2026 | 1.072 |
| October 27, 2026 | 1.080 |
| October 26, 2026 | 1.055 |
| October 23, 2026 | 1.096 |
| October 22, 2026 | 1.121 |
| October 21, 2026 | 1.121 |
| October 20, 2026 | 1.121 |
| October 19, 2026 | 1.030 |
| October 16, 2026 | 1.080 |
| October 15, 2026 | 1.220 |
| October 14, 2026 | 1.228 |
| October 13, 2026 | 1.220 |
| October 12, 2026 | 1.245 |
| October 09, 2026 | 1.228 |
| October 08, 2026 | 1.270 |
| October 07, 2026 | 1.261 |
| October 06, 2026 | 1.319 |
| October 05, 2026 | 1.356 |
| Date | Value |
|---|---|
| October 02, 2026 | 1.500 |
| October 01, 2026 | 1.558 |
| September 30, 2026 | 1.665 |
| September 29, 2026 | 1.946 |
| September 28, 2026 | 1.937 |
| September 25, 2026 | 1.962 |
| September 24, 2026 | 1.929 |
| September 23, 2026 | 1.937 |
| September 22, 2026 | 2.036 |
| September 21, 2026 | 1.978 |
| September 18, 2026 | 1.995 |
| September 17, 2026 | 1.987 |
| September 16, 2026 | 1.946 |
| September 15, 2026 | 2.011 |
| September 14, 2026 | 2.143 |
| September 11, 2026 | 2.160 |
| September 10, 2026 | 2.193 |
| September 09, 2026 | 2.267 |
| September 08, 2026 | 2.349 |
| September 04, 2026 | 2.358 |
| September 03, 2026 | 2.349 |
| September 02, 2026 | 2.382 |
| September 01, 2026 | 2.366 |
| August 31, 2026 | 2.308 |
| August 28, 2026 | 2.465 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Vaxcyte, Inc. | 3.832 |
| Foghorn Therapeutics, Inc. | -- |
| Connect Biopharma Holdings Ltd. | 1.708 |
| Caribou Biosciences, Inc. | 0.6326 |
| Arrowhead Pharmaceuticals, Inc. | 17.63 |
Price to Book Value Related Metrics
| Price | 1.15 |
| Earnings Yield | -13.18% |
| Market Cap | 106.60M |